To evaluate if COPS5 protein overexpression is involved in tamoxifen-resistance, we investigated ERα+ breast tumours that were untreated (n=31) or refractory to tamoxifen-treatment (n=30). This evidence concerns the gene ESR1 and breast neoplasm.